DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN AIDS PATIENTS USING AMPLIFICATION-MEDIATED HYBRIDIZATION ANALYSES - REPRODUCIBILITY AND QUANTITATIVE LIMITATIONS

被引:42
作者
DAVIS, GR
BLUMEYER, K
DIMICHELE, LJ
WHITFIELD, KM
CHAPPELLE, H
RIGGS, N
GHOSH, SS
KAO, PM
FAHY, E
KWOH, DY
GUATELLI, JC
SPECTOR, SA
RICHMAN, DD
GINGERAS, TR
机构
[1] SALK INST BIOTECHNOL IND ASSOCIATES,POB 85200,SAN DIEGO,CA 92138
[2] UNIV CALIF SAN DIEGO,SCH MED,DEPT MED,LA JOLLA,CA 92093
[3] UNIV CALIF SAN DIEGO,SCH MED,DEPT PATHOL,LA JOLLA,CA 92093
[4] VET ADM MED CTR,SAN DIEGO,CA 92161
[5] UNIV CALIF SAN DIEGO,SCH MED,DEPT PEDIAT,LA JOLLA,CA 92093
关键词
D O I
10.1093/infdis/162.1.13
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Eighty-six peripheral blood mononuclear cell (PBMC) samples from 30 patients with AIDS were analyzed using a transcription-based amplification system (TAS) and the polymerase chain reaction (PCR). Human immunodeficiency virus type 1 (Hlv-l) sequences were detected by amplification- mediated hybridization in 98% of the samples, 52% of which were positive for p24 antigen by ELISA. Neither TAS (93%) nor PCR (95%) detected HIV-1 sequences in all 86 samples. The hybridization-detection methods (slot blot, bead-based sandwich, and solution) used to detect the HIV-1-specific TAS products had a clear influence on the efficiency of detecting and quantitating the levels of HIV-1 present in these samples. The reproducibility of amplification of constant amounts of HIV-1 RNA and β-globinDNA by TAS and PCR was studied over 3 months. The results indicated that variations of 10- and 5-fold in the HIV-1 sequence levels could bedetected between samples by TASand PCR, respectively. Within the range of sensitivities for each assay used, the administration of zidovudine did not appear to reduce the amount of HIV-1 nucleic acid sequences as observed in PBMC obtained serially from six AIDS patients. © 1990 by The University of Chicago.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 22 条
[1]   ENZYMATIC GENE AMPLIFICATION - QUALITATIVE AND QUANTITATIVE METHODS FOR DETECTING PROVIRAL DNA AMPLIFIED INVITRO [J].
ABBOTT, MA ;
POIESZ, BJ ;
BYRNE, BC ;
KWOK, S ;
SNINSKY, JJ ;
EHRLICH, GD .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (06) :1158-1169
[2]   PREPARATION OF PEPTIDE-PROTEIN IMMUNOGENS USING N-SUCCINIMIDYL BROMOACETATE AS A HETEROBIFUNCTIONAL CROSS-LINKING REAGENT [J].
BERNATOWICZ, MS ;
MATSUEDA, GR .
ANALYTICAL BIOCHEMISTRY, 1986, 155 (01) :95-102
[3]   DERIVATIZATION OF UNPROTECTED POLYNUCLEOTIDES [J].
CHU, BCF ;
WAHL, GM ;
ORGEL, LE .
NUCLEIC ACIDS RESEARCH, 1983, 11 (18) :6513-6529
[4]   PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
COOMBS, RW ;
COLLIER, AC ;
ALLAIN, JP ;
NIKORA, B ;
LEUTHER, M ;
GJERSET, GF ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1626-1631
[5]  
GINGERAS TR, IN PRESS J VET MICRO
[6]   NUCLEIC-ACID AMPLIFICATION INVITRO - DETECTION OF SEQUENCES WITH LOW COPY NUMBERS AND APPLICATION TO DIAGNOSIS OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 INFECTION [J].
GUATELLI, JC ;
GINGERAS, TR ;
RICHMAN, DD .
CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 (02) :217-226
[7]  
HART C, 1988, LANCET, V2, P596
[8]   QUANTITATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN THE BLOOD OF INFECTED PERSONS [J].
HO, DD ;
MOUDGIL, T ;
ALAM, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1621-1625
[9]   TRANSCRIPTION-BASED AMPLIFICATION SYSTEM AND DETECTION OF AMPLIFIED HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 WITH A BEAD-BASED SANDWICH HYBRIDIZATION FORMAT [J].
KWOH, DY ;
DAVIS, GR ;
WHITFIELD, KM ;
CHAPPELLE, HL ;
DIMICHELE, LJ ;
GINGERAS, TR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) :1173-1177
[10]   IDENTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS SEQUENCES BY USING INVITRO ENZYMATIC AMPLIFICATION AND OLIGOMER CLEAVAGE DETECTION [J].
KWOK, S ;
MACK, DH ;
MULLIS, KB ;
POIESZ, B ;
EHRLICH, G ;
BLAIR, D ;
FRIEDMANKIEN, A ;
SNINSKY, JJ .
JOURNAL OF VIROLOGY, 1987, 61 (05) :1690-1694